In this issue of Current Oncology
2006
Updates on Prostate Cancer Treatment and Pandemic Preparedness
Editorial
Author Information
Author(s): McLean M.
Conclusion
The introduction of docetaxel has significantly improved treatment options for prostate cancer, and there are ongoing discussions about the unique needs of cancer patients during a pandemic.
Supporting Evidence
- Chemotherapy combined with androgen deprivation is being explored for high-risk prostate cancer.
- Mitoxantrone and steroids improved quality of life for prostate cancer patients in 1994.
- Docetaxel has been shown to prolong the lives of men with hormone-refractory prostate cancer.
- Variations in radiation practices were observed between Canadian and U.S. cancer treatment centers.
- Few effective strategies for promoting a healthy diet were identified, indicating a need for controlled studies.
Takeaway
Doctors are finding new ways to help men with prostate cancer live longer, and they are also thinking about how to take care of cancer patients if there is a pandemic.
Want to read the original?
Access the complete publication on the publisher's website